KIDS
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
OrthoPediatrics Corp. (KIDS) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Value (D).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-13 | D (1.5) | C+ (2.6) | B (3.5) | B+ (3.8) | C+ (2.6) | C+ (2.8) |
| 2026-11-06 | D+ (1.5) | C+ (2.6) | B (3.5) | A- (4.0) | C+ (2.7) | C+ (2.8) |
| 2026-10-30 | C+ (2.5) | C+ (2.5) | B+ (3.5) | A (4.2) | C+ (2.7) | B- (3.1) |
| 2026-10-23 | B- (3.0) | C+ (2.6) | B (3.4) | B+ (3.8) | C+ (2.6) | B- (3.1) |
| 2026-10-16 | B- (3.0) | C+ (2.6) | B (3.4) | B+ (3.7) | C+ (2.6) | B- (3.1) |